It has been found that SRPK1 was a genetic vulnerability of acute myeloid leukemia (AML) through effects on isoform usage of epigenetic regulators including BRD4 (Tzelepis et al., 2018). The gene discussed is BRD4; the disease is acute myeloid leukemia.